89bio, Inc. - Price History
Monthly price history for ETNB (89bio, Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| April 2024 | $10.58 | $10.58 |
| March 2024 | $11.64 | $11.64 |
| February 2024 | $11.47 | $11.47 |
| January 2024 | $9.90 | $9.90 |
| December 2023 | $11.17 | $11.17 |
| November 2023 | $8.04 | $8.04 |
| October 2023 | $7.40 | $7.40 |
| September 2023 | $15.44 | $15.44 |
| August 2023 | $17.14 | $17.14 |
| July 2023 | $15.84 | $15.84 |
| June 2023 | $18.95 | $18.95 |
| May 2023 | $18.23 | $18.23 |
| April 2023 | $15.98 | $15.98 |
| March 2023 | $15.23 | $15.23 |
| February 2023 | $13.62 | $13.62 |
| January 2023 | $11.68 | $11.68 |
| December 2022 | $12.73 | $12.73 |
| November 2022 | $8 | $8 |
| October 2022 | $9.55 | $9.55 |
| September 2022 | $5.79 | $5.79 |
| August 2022 | $4.46 | $4.46 |
| July 2022 | $3.55 | $3.55 |
| June 2022 | $3.22 | $3.22 |
| May 2022 | $3.01 | $3.01 |
| April 2022 | $2.17 | $2.17 |
| March 2022 | $3.77 | $3.77 |
| February 2022 | $4.63 | $4.63 |
| January 2022 | $5.89 | $5.89 |
| December 2021 | $13.07 | $13.07 |
| November 2021 | $13.21 | $13.21 |
| October 2021 | $17.60 | $17.60 |
| September 2021 | $19.59 | $19.59 |
| August 2021 | $18.51 | $18.51 |
| July 2021 | $15.66 | $15.66 |
| June 2021 | $18.70 | $18.70 |
| May 2021 | $18.90 | $18.90 |
| April 2021 | $26.29 | $26.29 |
| March 2021 | $23.68 | $23.68 |
| February 2021 | $24.56 | $24.56 |
| January 2021 | $20.30 | $20.30 |
| December 2020 | $24.37 | $24.37 |
| November 2020 | $27.01 | $27.01 |
| October 2020 | $23.16 | $23.16 |
| September 2020 | $25.66 | $25.66 |
| August 2020 | $38.50 | $38.50 |
| July 2020 | $30.38 | $30.38 |
| June 2020 | $19.93 | $19.93 |
| May 2020 | $25.76 | $25.76 |
| April 2020 | $23.51 | $23.51 |
| March 2020 | $25.25 | $25.25 |
| February 2020 | $35.67 | $35.67 |
| January 2020 | $26.72 | $26.72 |
| December 2019 | $26.29 | $26.29 |
| November 2019 | $31.27 | $31.27 |
ETNB
Price: $8.26
52 week price:
Earnings Per Share: -2.00 USD
P/E Ratio: -5.21
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Market Capitalization: 1.0 billion